Table 1 Characteristics of the patients (number = 19)
Number of patients | Percentage (%) | |
|---|---|---|
Gender | ||
Male | 11 | 57.9 |
Female | 8 | 42.1 |
Median age | 56(19 to 86) | |
Primary tumor stage | ||
Stage I | 1 | 5.3 |
Stage II | 4 | 21.1 |
Stage III | 7 | 36.8 |
Stage IV | 7 | 36.8 |
Primary tumor | ||
Larynx | 6 | 31.6 |
Soft tissue sarcoma | 3 | 15.8 |
Hypopharynx carcinoma | 2 | 10.5 |
Thyroid carcinoma | 2 | 10.5 |
Cancer of nasal cavities | 2 | 10.5 |
Nasopharynx carcinoma | 1 | 5.3 |
Submandibular gland carcinoma | 1 | 5.3 |
Maxillary sinus carcinoma | 1 | 5.3 |
Merkel’s cells tumor of left ear | 1 | 5.3 |
Tumor pathology | ||
Squamous cell carcinoma | 9 | 47.4 |
Adenoid cystic carcinoma | 2 | 10.5 |
Small cell carcinoma | 1 | 5.3 |
Chondrosarcoma | 1 | 5.3 |
Neurofibrosarcoma | 1 | 5.3 |
Rhabdomyosarcoma | 1 | 5.3 |
Medullary carcinoma | 1 | 5.3 |
Papillary adenocarcinoma | 1 | 5.3 |
Malignant melanoma | 1 | 5.3 |
Merkel’s cells tumor | 1 | 5.3 |
Previous surgery | 19 | 100 |
One | 12 | 63.2 |
Two | 6 | 31.6 |
Three | 1 | 5.2 |
Previous chemotherapy | 5 | 26.3 |
Previous radiotherapy | 19 | 100 |
One | 12 | 63.1 |
Two | 6 | 31.6 |
Three | 1 | 5.3 |
Previous cumulative dose (Gy) | ||
≤50 Gy | 3 | 15.8 |
50 to 100 Gy | 13 | 68.4 |
>100 Gy | 3 | 15.8 |
Median dose(Gy) | 64(34 to 14) |